-
Mashup Score: 0
Use of the CytospongeTM is safe, tolerable, and acceptable for the assessment of treatment response following CRT in OAC and OSCC. Further evaluation of Cytosponge™ in this setting is warranted.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Pathological LN regression after neoadjuvant chemotherapy was a strong prognostic factor and provides important information beyond pathological TNM staging and primary tumor regression grading. LN regression should be included as standard in the pathological reporting of esophagectomy specimens.
Source: pubmed.ncbi.nlm.nih.govCategories: Latest Headlines, Oncologists2Tweet-
A monumental effort led by Andrew Davies. Lymph node regression provides additional prognostic information beyond response in the primary tumour. Many thanks to all of the pathologists who worked so hard on this. #oesophagealcancer #biomarkers https://t.co/DYjVoqi6Un
-
-
Mashup Score: 1ESMO Living Guidelines | ESMO - 10 month(s) ago
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Just out 📢 The ESMO #GastricCancer Living Guideline. Updates in 1st-, 2nd- & further lines of tx of advanced/metastatic unresectable #OesophagealCancer, #OesophagogastricJunctionCancer & #GastricAdenocarcinoma; & supportive care & nutrition. 🔗 https://t.co/XxmGo356Pq #esocsm https://t.co/7LYaeqBrmC
-
-
Mashup Score: 0Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time - 12 month(s) ago
Background The subtypes of gastric cancer (GC) and oesophageal cancer (EC) manifest distinct epidemiological profiles. Here, we aim to examine correlations in their incidence rates and to compare their temporal changes globally, both overall and by subtype. Methods Long-term incidence data were obtained from population-based registries available from the Cancer Incidence in Five Continents…
Source: GutCategories: Gastroenterology, Latest HeadlinesTweet-
#GUTImage from the paper by @melina1arnold @valmacsee et al om "Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time" via https://t.co/xuHSSuzx5Z #GastricCancer #OesophagealCancer #GOJ https://t.co/nGchlxw18u
-
-
Mashup Score: 0Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time - 1 year(s) ago
Background The subtypes of gastric cancer (GC) and oesophageal cancer (EC) manifest distinct epidemiological profiles. Here, we aim to examine correlations in their incidence rates and to compare their temporal changes globally, both overall and by subtype. Methods Long-term incidence data were obtained from population-based registries available from the Cancer Incidence in Five Continents…
Source: GutCategories: Gastroenterology, Latest HeadlinesTweet-
#GUTImage from the paper by @melina1arnold @valmacsee et al om "Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time" via https://t.co/xuHSSuzx5Z #GastricCancer #OesophagealCancer #GOJ https://t.co/Rn46r0dRTS
-
-
Mashup Score: 1Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time - 1 year(s) ago
Background The subtypes of gastric cancer (GC) and oesophageal cancer (EC) manifest distinct epidemiological profiles. Here, we aim to examine correlations in their incidence rates and to compare their temporal changes globally, both overall and by subtype. Methods Long-term incidence data were obtained from population-based registries available from the Cancer Incidence in Five Continents…
Source: GutCategories: Gastroenterology, Latest HeadlinesTweet-
#GUTImage from the paper by @melina1arnold @valmacsee et al om "Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time" via https://t.co/xuHSSuzx5Z #GastricCancer #OesophagealCancer #GOJ https://t.co/hBREzAZVcw
-
-
Mashup Score: 1Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time - 1 year(s) ago
Background The subtypes of gastric cancer (GC) and oesophageal cancer (EC) manifest distinct epidemiological profiles. Here, we aim to examine correlations in their incidence rates and to compare their temporal changes globally, both overall and by subtype. Methods Long-term incidence data were obtained from population-based registries available from the Cancer Incidence in Five Continents…
Source: GutCategories: Gastroenterology, Latest HeadlinesTweet-
#GUTImage from the paper by @melina1arnold @valmacsee et al om "Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time" via https://t.co/xuHSSuzx5Z #GastricCancer #OesophagealCancer #GOJ https://t.co/IKrdgudasG
-
-
Mashup Score: 1
ESMO Guidelines: Real World Cases – Oesophageal CancerChair: Elizabeth SmythSpeakers: Marin Golčić, Radka Obermannova, Henk van Halteren
Source: oncologypro.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#OesophagealCancer: Discover how the ESMO Guidelines can assist in your decision-making for the treatment of challenging, real-world cases. Access the resources now for this thought-provoking presentation: https://t.co/woHpofxv7J @LizzySmyth1 #EsophagealCancer #esocsm https://t.co/ce9wt052C3
-
-
Mashup Score: 2ESMO Guidelines: Real World Cases - Webinar Series: Oesophageal - 1 year(s) ago
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#OesophagealCancer webinar airing tomorrow (29/3) 👉 a unique opportunity to learn from the ESMO Guideline experts & get your questions answered. 29 Mar, 18:30 CEST Access with your free ESMO account: https://t.co/evuDleRP9C @LizzySmyth1 @RadkaObermanno1 #EsophagealCancer #esocsm https://t.co/Q2O9bKUtSE
-
-
Mashup Score: 5ESMO Guidelines: Real World Cases - Webinar Series: Oesophageal - 1 year(s) ago
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#OesophagealCancer webinar 👉 Get your questions answered by ESMO Guidelines experts & elevate your patient care in real-world clinical settings. 29 Mar, 18:30 CEST Access with your free ESMO account: https://t.co/evuDleRP9C @LizzySmyth1 @RadkaObermanno1 #EsophagealCancer #esocsm https://t.co/0yzRYZcyzT
-
Use of a non-endoscopic immunocytological device (Cytosponge) for post- chemoradiotherapy surveillance in patients with #oesophageal #cancer in the UK Results suggested that the Cytosponge is safe, tolerable, and acceptable https://t.co/TVtEiJ2ExV 2/9 https://t.co/MzmMmb44n0